echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > AQSIQ: recall Fonterra contaminated milk powder immediately

    AQSIQ: recall Fonterra contaminated milk powder immediately

    • Last Update: 2013-08-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In response to the detection of Botox in whey protein concentrate by New Zealand enterprises, AQSIQ asked importers to recall the products that may have been contaminated immediately Tuesday night Fonterra New Zealand announced that Botox was detected in the concentrated whey protein powder produced in May 2012 in a factory of Fonterra New Zealand AQSIQ attached great importance to this and immediately contacted the Embassy of New Zealand in China, asking New Zealand to take immediate measures to prevent the problem products from affecting the health of Chinese consumers AQSIQ requires importers to recall products that may be contaminated immediately and local inspection and quarantine agencies to further strengthen the inspection and supervision of New Zealand's dairy products exported to China AQSIQ will continue to pay attention to this matter ■ it is suspected that 8 manufacturers with 40 tons of contaminated milk powder may be affected and used in infant formula milk powder and sports drink production; Fonterra declined to disclose the product name, according to Xinhua news agency, New Zealand's Ministry of primary industry announced Wednesday that the sub products of New Zealand dairy giant Fonterra group may contain botulinum toxin Potentially contaminated products are used in the production of infant formula and sports drinks Scott Gallagher, acting director of food safety of the Ministry of primary industry, said in a statement that Fonterra group informed the Ministry of primary industry of the incident on the afternoon of the 2nd, and the Ministry of primary industry had informed the government regulators of major overseas markets of the situation and intensified investigation and verification Gallagher said that the Ministry of primary industry will first investigate whether the contaminated products flow into the New Zealand market The Ministry of primary industry will also work with Fonterra and related customers to confirm whether there are products that pose risks If products on the market are found to contain contaminated proteins, they will be recalled Fonterra group held a press conference yesterday, announcing more details of the pollution problem Gary Romano, executive director of Fonterra group's New Zealand dairy products company, said there were quality problems with three batches of concentrated whey protein, which were produced in a local New Zealand factory in May last year, with a total of 40 tons of suspected contaminated products The source of the pollution was a contaminated pipeline at the company's hotap plant in the North Island region of Waikato Fonterra group said the test results showed that the concentrated whey protein may contain strains of Botox, which may cause poisoning to consumers According to reports, this concentrated whey protein is widely used in infant milk powder, children's growth milk powder and sports drinks But general dairy products, such as fresh milk, cheese, yoghurt and milk products sterilized by ultra-high temperature, will not be affected At present, no reports of health problems caused by defective products have been received It is reported that the contaminated concentrated whey protein powder, which may cause poisoning to the eaters, has been provided to eight manufacturers as raw materials for the production of infant milk powder, children's growth milk powder and sports drinks, and the products involved are estimated to reach 900 tons On Tuesday, Fonterra group reported the situation to eight customers At present, these customers have launched an urgent investigation to see if the products are affected If necessary, the product will be recalled A spokesman for the group said the names of the eight companies and related products could not be disclosed at present, nor which countries the products were sold to But New Zealand's Ministry of primary industry said the affected countries included Australia, China, Malaysia, Thailand, Vietnam and Saudi Arabia Fonterra's global chief executive, David spiegens, is scheduled to travel to China from Europe on the 3rd to update relevant institutions and customers The group will do its best to assist the eight customers in carrying out inspections to ensure that the infected products are recovered from the market, Mr spitgens said ■ the term explains that Botox is a Gram-positive bacterium that grows in a normal temperature, low acid and anoxic environment Botox can grow in improperly processed, packaged, stored canned or vacuum packaged foods The main clinical manifestations of Botox food poisoning are nausea, vomiting and central nervous system symptoms such as ophthalmoplegia and pharyngeal paralysis If the rescue is not timely, the mortality is high.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.